Dr. Stephen Riady (former name: Stephen Tjondro Riady), aged 62, was appointed a Director of the Company in July 1992 and is the Chairman of board of directors of the Company. Dr. Riady is also an executive director and the Chairman of the board of directors of Lippo Limited (“Lippo”) and Hongkong Chinese Limited (“HKC”), both are public listed companies in Hong Kong. He has been the Executive President of each of the Company, Lippo and HKC since January 2015. He is a member of the Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC. Dr. Riady also holds directorships in certain subsidiaries of the Company, Lippo and HKC. He is the Executive Chairman and Group Chief Executive Officer of OUE Limited (“OUE”), a company listed on the Mainboard of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). He is a non-executive non-independent director of Healthway Medical Corporation Limited, a company listed on the sponsor-supervised listing platform of the SGX-ST. Dr. Riady is a director of Lippo Capital Group Limited, Lippo Capital Holdings Company Limited, Lippo Capital Limited and Skyscraper Realty Limited (“Skyscraper”) which, together with Lippo, have discloseable interests in the Company under the provisions of the Securities and Futures Ordinance. Dr. Riady is a graduate of the University of Southern California, United States of America and holds a Master of Business Administration from Golden Gate University, United States of America and an Honorary Degree of Doctor of Business Administration from Edinburgh Napier University, United Kingdom. He is one of the first Honorary University Fellows installed by the Hong Kong Baptist University in September 2006. Dr. Riady is the father of Mr. Brian Riady who is an executive Director of each of the Company, Lippo and HKC and a director of certain subsidiaries of the Company. Dr. Riady is the father-in-law of Dr. Andy Adhiwana (“Dr. Adhiwana”), an executive director and the Group Chief Executive Officer of Auric Pacific Group Limited, a subsidiary of the Company. Dr. Riady is the spouse of Madam Shincee Leonardi (“Madam Leonardi”) and a brother of Mr. James Tjahaja Riady (“Mr. James Riady”). Madam Aileen Hambali (“Madam Hambali”) is the spouse of Mr. James Riady. Interests of Madam Leonardi, Mr. James Riady and Madam Hambali in the Company are disclosed in the section headed “Interests and short positions of shareholders discloseable under the Securities and Futures Ordinance” in the Report of Directors in the 2022 Annual Report of the Company.

Mr. John Luen Wai Lee, BBS, JP, aged 74, was appointed a Director of the Company in July 1992 and is the Chief Executive Officer of the Company. Mr. Lee is the Managing Director and Chief Executive Officer of Lippo. He is an executive director and the Chief Executive Officer of HKC, as well as an independent non-executive director of New World Development Company Limited and UMP Healthcare Holdings Limited, both are public listed companies in Hong Kong. He is a director of Skyscraper. Mr. Lee is an authorised representative of the Company, Lippo and HKC. In addition, he holds directorships in certain subsidiaries of the Company, Lippo and HKC. Mr. Lee is a Fellow of The Institute of Chartered Accountants in England and Wales, the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants. He was a partner of Price Waterhouse (now known as PricewaterhouseCoopers) in Hong Kong and has extensive experience in corporate finance and capital markets. Mr. Lee is an Honorary Fellow of the City University of Hong Kong, a Justice of Peace in Hong Kong and an awardee of the Bronze Bauhinia Star by the Government of the Hong Kong Special Administrative Region. Mr. Lee is active in public service. Over the years, he has served as a member or chairman of different government boards and committees in Hong Kong, including a member of the Hong Kong Hospital Authority and the Chairman of the Hospital Governing Committee of the Queen Elizabeth Hospital. Currently, he serves as the Chairman of the Hospital Governing Committee of Hong Kong Children’s Hospital.

Mr. James Siu Lung Lee, aged 53, was appointed an executive Director of the Company in May 2015. Mr. Lee has over 20 years of experience in mergers and acquisitions on technology companies. Mr. Lee joined a former subsidiary of HKC in 1997 and was the Head of Derivatives Department before he left that subsidiary in late 1999. Mr. Lee was subsequently appointed as an assistant to the then Managing Director of the Company in early 2000 and left the Company in early 2009. He was a director of Systech Century Group from 2009 to 2014. In December 2014, Mr. Lee rejoined the Group and was appointed an Executive Vice President of business development. He also holds directorships in certain subsidiaries of the Company. Mr. Lee holds a Bachelor degree in Manufacturing Engineering with honours from Queen’s University, Belfast, United Kingdom and a Doctor degree in Engineering (major in Hierarchical Operations Management and Control for Automated Systems and Robotics) from The University of Hong Kong. He also holds a Master of Laws (major in International Economic Law) from The Chinese University of Hong Kong.

Mr. Brian Riady, aged 32, was appointed an executive Director of the Company in March 2023. Mr. Riady holds a Bachelor of Science (Political Communication) and a Bachelor of Arts (Economics) from the University of Texas at Austin, the United States of America. He attended the Executive Education programs at the Harvard Business School. Mr. Riady is also an executive director of Lippo and HKC. He is the Deputy Chief Executive Officer and Executive Director of OUE and a non-independent and non-executive director of OUE Lippo Healthcare Limited (“OUELH”). Mr. Riady is also a non-independent non-executive director of OUE Commercial REIT Management Pte. Ltd. (the manager of OUE Commercial Real Estate Investment Trust (“OUE C-REIT”)). OUELH and OUE C-REIT are listed on the SGX-ST. He also holds directorships in certain subsidiaries of the Company. Mr. Riady is the son of Dr. Stephen Riady and Madam Leonardi and a brother-in-law of Dr. Adhiwana. Mr. Riady is a nephew of Mr. James Riady and Madam Hambali.

Mr. Leon Nim Leung Chan, aged 67, was appointed an independent non-executive Director of the Company in May 1997 and was re-designated as a non-executive Director of the Company in September 2004. He is a practising lawyer and presently the principal partner of Messrs. Y.T. Chan & Co. He was admitted as a solicitor of the Supreme Court of Hong Kong in 1980 and was also admitted as a solicitor in England in 1984 and in Victoria, Australia in 1985. He was a member of the Solicitors Disciplinary Tribunal from May 1993 to April 2008. He is also a non-executive director of Lippo and HKC. Mr. Chan is a member of the Audit Committee, Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC.

Mr. Edwin Neo, aged 73, was appointed an independent non-executive Director of the Company in March 2002. He was admitted as a solicitor of the Supreme Court of Hong Kong in 1976 and of the Supreme Court of England and Wales in 1993. Mr. Neo is a practising lawyer and a notary public and is presently the senior partner of Hoosenally & Neo, Solicitors & Notaries. Mr. Neo holds a Bachelor of Laws degree with honours and Post-graduate Certificate in Laws from The University of Hong Kong. He is also an independent non-executive director of HKC. Mr. Neo is the Chairman of the Remuneration Committee and Nomination Committee and a member of the Audit Committee of the Company. He is also a member of the Remuneration Committee, Nomination Committee and Audit Committee of HKC. He resigned as an independent non-executive director of Lippo in December 2022.

Mr. Victor Ha Kuk Yung, aged 69, was appointed an independent non-executive Director of the Company in September 2004. Mr. Yung is a professional accountant with over 40 years of working experience in the financial and accounting fields, and served in management positions in various multinational companies in Asia. Mr. Yung holds a Master of Science Degree in Corporate Governance and Directorship from the Hong Kong Baptist University, and is a member of the Hong Kong Institute of Certified Public Accountants. He is also an independent non-executive director of Lippo. Mr. Yung is the Chairman of the Audit Committee and a member of the Remuneration Committee and Nomination Committee of each of the Company and Lippo. Mr. Yung resigned as an independent non-executive director of Travel Expert (Asia) Enterprises Limited, a public listed company in Hong Kong, in November 2022. Mr. Yung also resigned as an independent non-executive director of HKC in December 2022.

Ms Min Yen Goh, aged 62, was appointed an independent non-executive Director of the Company in December 2022. Ms. Goh obtained a Bachelor of Science in Economics and Finance with high distinction from Babson College in the United States of America. Ms. Goh is currently the managing director of Eng Wah Group and a director of Eng Wah Global Pte. Ltd. Ms. Goh was a director of Eng Wah Organization Limited, which was listed on the Mainboard of the SGX-ST before it was privatized in 2008. She is an independent director and a member of the nominating committee and remuneration committee of OUE. Ms. Goh is also an independent non-executive director of Lippo and HKC. Ms. Goh is a member of the Remuneration Committee and Nomination Committee of each of the Company, Lippo and HKC.